[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Stakeholder](https://github.com/mm80843/T3.5/tree/pages/docs/Stakeholder/index.md) >> Individual ID:PBN__Stakeholder_2877 

# __And healthcare professionals__

## Risk affecting this stakeholder

* [Associations between greenspace and communicable diseases not considered](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3626.md)
* [Comparison of sars-cov-2 with sars-cov-1](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_3640.md)
* [Concerns about more transmissible variants of covid-19 impacting efforts to suppress the spread of the disease.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_5203.md)
* [Conducting meta-analyses without proper consideration of study quality and bias may lead to inaccurate conclusions.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6078.md)
* [Differences in geographical environmental factors impacting the effectiveness of covid-19 prevention and control measures](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6515.md)
* [Discovery of virus with genomic similarity to sars-cov-2 raises concerns about potential for human transmission.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6876.md)
* [Disparities in referral rates for rural women with ovarian cancer](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6929.md)
* [Dual challenge of anticipating demands and responding to emergencies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_6930.md)
* [Emergence of epidemic diseases impacting sustainable development](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_7996.md)
* [Failure to consider the impact of biophilic design on airborne disease transmission and contagion within the built environment.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8471.md)
* [Failure to consolidate public policies and administrative actions during periods of declining disease curve, leading to complacency and inadequate preparedness for future outbreaks.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_8503.md)
* [Hidden transmission of the virus by carriers who are unaware of their infection status.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_9450.md)
* [Inadequate measures for absorption of immediate aftermath of the pandemic](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10260.md)
* [Incomplete coverage of drug information in existing ontologies](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_10303.md)
* [Lack of scientific advances and knowledge about diseases](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12427.md)
* [Lack of standardization in data collection and annotation for covid-19 medication](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_12869.md)
* [Limited capabilities in addressing technical challenges of covid-19 analytics](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13610.md)
* [Poor contact with skin leading to compromised sensor accuracy](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_13760.md)
* [Risk of misinformation and misinterpretation](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14751.md)
* [Significant research gaps in understanding the association of built environment be attributes with the spread of covid-19.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_14878.md)
* [Skin irritation and discomfort from prolonged wear of sensors and wearables](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16249.md)
* [Unamplified synthetic dna used to set up pcr conditions may introduce contamination during subsequent experiments.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17737.md)
* [Uncertainty in understanding the transmission pathways of covid-19 leading to ineffective control measures.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18150.md)
* [Use of big data analytics may lead to over-reliance on technology and neglect of human input in decision-making.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19321.md)
* [Use of nested pcr with multiple cycles can increase the risk of contamination and false positives.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19624.md)
* [Utilization of advanced rna detection methods like crispr and dpcr for virus detection and quantification presents the risk of misinterpretation or inadequate understanding of the results compared to traditional methods like rt-qpcr.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_19625.md)

## Risks that can be mitigated by this stakeholder

* [Challenges of implementing blockchain technology in health systems could lead to security vulnerabilities.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_15904.md)
* [Decreased immune defense due to excessive workload and irregular circadian sleep-wake rhythm](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_17983.md)
* [Estimating the number of infected people in the building based on global covid-19 data](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18490.md)
* [Use of mobile technology for covid-19 contact tracing and monitoring.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18773.md)

## This Stakeholder belongs to this Stakeholder Group

* [Health organisations](https://github.com/mm80843/T3.5/blob/pages/StakeholderGroup/PBN__StakeholderGroup_7.md)

## This Stakeholder belongs to this Stakeholder Subgroup

* [Medical and healthcare personnel](https://github.com/mm80843/T3.5/blob/pages/StakeholderSubgroup/PBN__StakeholderSubgroup_15.md)

